These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38874041)

  • 61. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer.
    Petrillo A; Fusco R; Petrillo M; Granata V; Bianco F; Di Marzo M; Delrio P; Tatangelo F; Botti G; Pecori B; Avallone A
    Jpn J Radiol; 2018 Oct; 36(10):611-621. PubMed ID: 30039258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer.
    Bedrikovetski S; Traeger L; Vather R; Moore JW; Sammour T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):365-373. PubMed ID: 36305516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapy.
    Tey J; Tan JK; Tan KK; Soon YY; Loi HY; Mohamed JSA; Bakulbhai PA; Ang B; Liang TY
    Ann Acad Med Singap; 2023 Jun; 52(6):289-295. PubMed ID: 38904510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes.
    Choi H; Yoon HJ; Kim TS; Oh JH; Kim DY; Kim SK
    Nucl Med Commun; 2013 Dec; 34(12):1166-73. PubMed ID: 24128896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI.
    Bellini D; Carbone I; Rengo M; Vicini S; Panvini N; Caruso D; Iannicelli E; Tombolini V; Laghi A
    Tomography; 2022 Aug; 8(4):2059-2072. PubMed ID: 36006071
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 67. Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Jiang D; Wang X; Wang Y; Philips D; Meng W; Xiong M; Zhao J; Sun L; He D; Li K
    Virchows Arch; 2019 Jul; 475(1):39-47. PubMed ID: 31056731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy.
    Ha HI; Kim AY; Yu CS; Park SH; Ha HK
    Eur Radiol; 2013 Dec; 23(12):3345-53. PubMed ID: 23812242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The value of MR T2WI signal intensity related parameters for predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer].
    Wan LJ; Zhang CD; Zhang HM; Meng YK; Ye F; Liu Y; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):837-843. PubMed ID: 31770851
    [No Abstract]   [Full Text] [Related]  

  • 70. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
    Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
    Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
    Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
    Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 74. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.
    Shen H; Jin Z; Chen Q; Zhang L; You J; Zhang S; Zhang B
    Radiol Med; 2024 Apr; 129(4):598-614. PubMed ID: 38512622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
    Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deep learning-based imaging reconstruction for MRI after neoadjuvant chemoradiotherapy for rectal cancer: effects on image quality and assessment of treatment response.
    Kim B; Lee CM; Jang JK; Kim J; Lim SB; Kim AY
    Abdom Radiol (NY); 2023 Jan; 48(1):201-210. PubMed ID: 36261505
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wen L; Liu J; Hu P; Bi F; Liu S; Jian L; Zhu S; Nie S; Cao F; Lu Q; Yu X; Liu K
    Acad Radiol; 2023 Sep; 30 Suppl 1():S176-S184. PubMed ID: 36739228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.